ArticleJournal of translational medicine2023

β-catenin-IRP2-primed iron availability to mitochondrial metabolism is druggable for active β-catenin-mediated cancer.

Yuting Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.